ODSY Odyssey Healthcare, Inc. featured news, full reports, and detailed charts
Odyssey Healthcare, Inc. (ODSY) Wrap Up:
We are one of the largest providers of hospice care in the United States in terms of both patient census and number of Medicare-certified hospice programs. We started in 1996 with a single hospice program; at year-end 2007 we provided care from 72 Medicare-certified hospice programs in 29 states. On March 6, 2008 we completed our acquisition of VistaCare, Inc (“VistaCare”). After the completion of the VistaCare acquisition we now serve approximately 12,000 patients and their families each day through approximately 110 Medicare-certified hospice locations in 30 states. Hospice services are designed to provide a wide range of care and services to terminally ill patients and their families. The first hospice in the United States opened in 1974. In 1982, Congress enacted legislation to create the Medicare hospice benefit, and hospice care became a covered Medicare benefit in 1983. We are highly dependent on the Medicare program. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f14%2f0000950134-08-004749.html#FIS_BUSINESS"Odyssey Healthcare Inc. (ODSY:NASDAQ)
Snapshot of Odyssey Healthcare Inc. (ODSY)
|
OPEN
$14.89
|
PREVIOUS CLOSE
$14.98
|
|
|
DAY HIGH
$15.12
|
DAY LOW
$14.87
|
|
|
52 WEEK HIGH
11/18/09 - $15.42
|
52 WEEK LOW
12/2/08 - $7.00
|
|
|
MARKET CAP
497.0M
|
AVERAGE VOLUME 3 mo
225.9K
|
|
|
DILUTED EPS TTM
$1.06
|
SHARES OUTSTANDING
33.1M
|
|
|
ODSY Does Not Pay Dividends
|
P/E TTM
14.1x
|
|
| K = Thousands M = Millions B = Billions | ||
ODSY Top Compensated Officers
Executives, Board Directors
Key developments for Odyssey Healthcare Inc. (ODSY)
Odyssey HealthCare Inc. announced financial results for the third quarter and nine months ended September 30, 2009. For the third quarter of 2009, net patient service revenue from continuing operations increased 6.0% to $175.2 million, compared with $165.2 million for the third quarter of 2008. The Company's net income attributable to company's stockholders for the third quarter of 2009 was $11.6 million, or $0.35 per diluted share, as compared with $5.9 million or $0.18 per diluted share, for the third quarter of 2008. The Company's EBITDA from continuing operations for the third quarter of 2009 was $22.3 million, compared with $13.6 million for the third quarter of 2008. For the nine months ended September 30, 2009, net patient service revenue from continuing operations was $513.1 million, compared with $448.8 million for the same nine-month period of 2008. The Company's net income attributable to Odyssey stockholders for the nine months ended September 30, 2009, was $28.8 million, or $0.87 per diluted share, as compared with $9.1 million, or $0.27 per diluted share, for the same period of 2008. The Company's EBITDA from continuing operations for the first nine months of 2009 was $56.8 million, compared with $31.6 million for the first nine months of 2008. The company also announced an update to the previously disclosed investigation conducted by the U.S. Department of Justice (DOJ) of alleged violations of the Federal False Claims Act and various state false claims acts related to VistaCare Inc., a subsidiary of the company, that arose from alleged conduct occurring prior to the company's acquisition of VistaCare. The basis of the investigation is now known to be a qui tam complaint filed by a former employee of VistaCare, which has been unsealed. In connection with the unsealing of the complaint, the DOJ has filed a notice with the court declining to intervene in the qui tam action at this time. While this should not be viewed as a final assessment by the DOJ of the merits of this qui tam action, the company considers this to be a positive development.
Odyssey Healthcare Inc. - Conference Presentation Calls
Odyssey Healthcare Inc., Q3 2009 Earnings Call, Oct 29 2009
ODSY Competitors
| Company | Last | Change |
| Chemed Corp | $45.19 USD | +0.16 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | ODSY | Industry Range |
| Price/Earnings | 14.1x |
|
| Price/Sales | 0.7x |
|
| Price/Book | 2.1x |
|
| Price/Cash Flow | 12.3x |
|
| TEV/Sales | 0.4x |
|
|
ODSY |
||
ODSY transactions
| Type Date |
Target |
|
Merger/Acquisition
July 13, 2009 |
Odyssey HealthCare of Oklahoma City, Inc. |